Medical Biotechnology, VTT Technical Research Centre of Finland, Turku, Finland.
PLoS One. 2013;8(4):e60930. doi: 10.1371/journal.pone.0060930. Epub 2013 Apr 5.
Cancer initiation and progression involve microRNAs that can function like tumor suppressors and oncogenes. The functional significance of most miRNAs is currently unknown. To determine systematically which microRNAs are essential for glioma growth, we screened a precursor microRNA library in three human glioblastoma and one astroglial cell line model systems. The most prominent and consistent cell proliferation-reducing hits were validated in secondary screening with an additional apoptosis endpoint. The functional screening data were integrated in the miRNA expression data to find underexpressed true functional tumor suppressor miRNAs. In addition, we used miRNA-target gene predictions and combined siRNA functional screening data to find the most probable miRNA-target gene pairs with a similar functional effect on proliferation. Nine novel functional miRNAs (hsa-miR-129, -136, -145, -155, -181b, -342-5p, -342-3p, -376a/b) in GBM cell lines were validated for their importance in glioma cell growth, and similar effects for six target genes (ROCK1, RHOA, MET, CSF1R, EIF2AK1, FGF7) of these miRNAs were shown functionally. The clinical significance of the functional hits was validated in miRNA expression data from the TCGA glioblastoma multiforme (GBM) tumor cohort. Five tumor suppressor miRNAs (hsa-miR-136, -145, -342, -129, -376a) showed significant underexpression in clinical GBM tumor samples from the TCGA GBM cohort further supporting the role of these miRNAs in vivo. Most importantly, higher hsa-miR-145 expression in GBM tumors yielded significantly better survival (p<0.005) in a subset of patients thus validating it as a genuine tumor suppressor miRNA. This systematic functional profiling provides important new knowledge about functionally relevant miRNAs in GBM biology and may offer new targets for treating glioma.
癌症的发生和发展涉及到能够作为肿瘤抑制因子和癌基因发挥作用的 microRNAs。大多数 microRNAs 的功能意义目前尚不清楚。为了系统地确定哪些 microRNAs 对神经胶质瘤的生长是必不可少的,我们在三种人类神经胶质瘤和一种星形胶质细胞系模型系统中筛选了一个前体 microRNA 文库。在使用另一个凋亡终点的二次筛选中,对最显著和一致的细胞增殖减少的命中进行了验证。将功能筛选数据整合到 microRNA 表达数据中,以找到表达下调的真正功能性肿瘤抑制 microRNAs。此外,我们还使用 microRNA-靶基因预测和组合 siRNA 功能筛选数据,找到了在增殖方面具有相似功能效应的最可能的 microRNA-靶基因对。在 GBM 细胞系中验证了 9 种新型功能性 microRNAs(hsa-miR-129、-136、-145、-155、-181b、-342-5p、-342-3p、-376a/b)对神经胶质瘤细胞生长的重要性,并且这些 microRNAs 的六个靶基因(ROCK1、RHOA、MET、CSF1R、EIF2AK1、FGF7)也显示出相似的功能效应。在 TCGA 胶质母细胞瘤多形性(GBM)肿瘤队列的 microRNA 表达数据中验证了功能命中的临床意义。在 TCGA GBM 队列的临床 GBM 肿瘤样本中,5 种肿瘤抑制 microRNAs(hsa-miR-136、-145、-342、-129、-376a)表达明显下调,进一步支持了这些 microRNAs 在体内的作用。最重要的是,在 GBM 肿瘤中高表达 hsa-miR-145 的患者的生存率显著提高(p<0.005),从而验证了其作为真正的肿瘤抑制 microRNA 的作用。这种系统的功能分析为 GBM 生物学中具有功能相关性的 microRNAs 提供了重要的新知识,并为治疗神经胶质瘤提供了新的靶点。